TRVI NASDAQ
Trevi Therapeutics, Inc.
1W: +4.0%
1M: -7.3%
3M: -26.2%
YTD: +12.3%
1Y: +27.0%
3Y: +645.8%
5Y: +1021.9%
$13.35
+0.84 (+6.71%)
Pre-Market: $12.25 (-1.10, -8.28%)
Weekly Expected Move ±5.9%
$11
$12
$13
$13
$14
Credit Risk of going bust: lower than 92% of companies Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Trevi Therapeutics, Inc. would be worth roughly what it owes.
Total debt $605K against a stock market value of $1.90B.
Distance to default 14.96 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $302K (short-term plus half of long-term), stock volatility 57.6%; Altman Z'' 39.15. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), Trevi Therapeutics, Inc. would be worth roughly what it owes.
Total debt $605K against a stock market value of $1.90B.
Distance to default 14.96 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $302K (short-term plus half of long-term), stock volatility 57.6%; Altman Z'' 39.15. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships5
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-06-21
Earliest Filing
2024-12-16
Latest Filing
partner: 3
investor: 2
Counterparties (Filed by TRVI)
5 relationshipsCompanies named in TRVI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Leerink Partners LLC | — | partner | Underwriter for the common stock offering | 2024-12-16 | View |
| Stifel, Nicolaus & Company, Incorporated | — | partner | Underwriter for the common stock offering | 2024-12-16 | View |
| Oppenheimer & Co. Inc. | OPY | partner | Underwriter for the common stock offering | 2024-12-16 | View |
| New Enterprise Associates 16, L.P. | — | investor | Purchased 1,851,852 shares of common stock and warrants for $3.0 million in a private placement. | 2021-10-19 | View |
| Lincoln Park Capital Fund, LLC | — | investor | Investor entering into a purchase agreement to acquire up to $15.0 million of common stock. | 2021-06-21 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-06-04 | Bylaws Amendment; Shareholder Vote; Exhibits | View | |
| 2026-05-05 | Earnings Release; Exhibits | View | |
| 2026-04-17 | Material Agreement; Earnings Release; Other Events; Exhibits | Agreement | View |
| 2026-03-17 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-03-09 | Other Events | View | |
| 2025-12-05 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-20 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-17 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-06-04 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-06-02 | Other Events | View | |
| 2025-06-02 | Other Events | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-18 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-10 | Other Events | View | |
| 2025-01-08 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2024-12-16 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2024-12-12 | Other Events | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR